Researchers predict a significant increase in the number of personalized medicines in development over the next five years. These therapies demand a cold supply chain. The globalization of clinical trials, the prevailing infrastructure and regulatory environment can impact the design of that supply chain. Learn how Thermo Fisher Scientific helped a client overcome significant transportation challenges during the expansion of its first cell therapy-based trial.

Share this:

Leave a Reply

Your email address will not be published. Required fields are marked *